HCPCS Level II · Drugs administered other than oral method
J2505Injection, pegfilgrastim, 6 mg
Terminated 12/31/2021
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2505
J2505 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, pegfilgrastim, 6 mg.
It was added to HCPCS effective 01/01/2004, and its current record took effect 01/01/2022.
It was terminated on 12/31/2021 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Injection, pegfilgrastim 6mg
- Date added
- 01/01/2004
- Action effective
- 01/01/2022
- Termination date
- 12/31/2021
- BETOS
- O1E
Related J25xx codes
- J2501Injection, paricalcitol, 1 mcg
- J2502Injection, pasireotide long acting, 1 mg
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2515Injection, pentobarbital sodium, per 50 mg
- J2516Injection, pentamidine isethionate, 1 mg
- J2540Injection, penicillin g potassium, up to 600,000 units
- J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
- J2547Injection, peramivir, 1 mg
Common questions about J2505
Is HCPCS J2505 still valid?
- No. J2505 was terminated on 12/31/2021.
Does Medicare cover J2505?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.